Varian Medical Systems, Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. It supplies tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems, Inc. is headquartered in Palo Alto, California.
Industry sector: Medical
Sector classification: Electromedical equipment
Deep Learning based analysis and prediction model for Varian Medical Systems, Inc. (VAR) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.
Model is in the production pipeline since Sept. 30, 2015.
Market data for VAR model training are being downloaded from the
Quandl premium datasets on a daily basis.
Risks related to the novel coronavirus disease 2019 (COVID-19) caused by the virus named “SARS-CoV-2” are
accounted for in this model in the form of the historical data coincided with outbreaks and other
global events in the past used to train ML prediction model for VAR.
Model is being retrained on a daily basis.
| Float | 91M |
| P/E | 26.78 |
| Shares Outstanding | 91M |
| % Held by Insiders | 0.78% |
| % Held by Institutions | 98.88% |
| EPS (last reported FY) | $3.60 |
| EPS (last reported Q) | $1.15 |
| EPS, estimated (last reported Q) | $1.06 |
| Total revenues | $3 B |
| Net income | $0 B |